Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) Total debt
Avantor, Inc.'s total debt at the end of fiscal 2025 was $3.9B, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $3.7B. Over the past ten years it has ranged from $1.3B (fiscal 2016) to $7.1B (fiscal 2017); the current reading is higher than 20% of that period. Avantor, Inc. ranks 6th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $3.9B | (2.70%) |
| FY2024 | $4.1B | (26.75%) |
| FY2023 | $5.5B | (11.94%) |
| FY2022 | $6.3B | (10.48%) |
| FY2021 | $7.0B | 43.51% |
| FY2020 | $4.9B | (4.35%) |
| FY2019 | $5.1B | (26.11%) |
| FY2018 | $6.9B | (2.72%) |
| FY2017 | $7.1B | 449.23% |
| FY2016 | $1.3B | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $3.7B | (0.38%) |
| Jun 2026 | $3.7B | (3.11%) |
| Mar 2026 | $3.8B | (3.29%) |
| Dec 2025 | $3.9B | 2.29% |
| 27 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| BAX Baxter International Inc. compare | $8.6B |
| BLCO Bausch + Lomb Corporation compare | $5.1B |
| AVTR Avantor, Inc. | $3.7B |
| TFX Teleflex Incorporated compare | $2.8B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| ATR AptarGroup, Inc. compare | $1.4B |
| RGEN Repligen Corporation compare | $555.6M |
| SOLV Solventum Corporation compare | $507.0M |
| ALGN Align Technology, Inc. compare | $127.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on AVTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement